Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice

Endocrinology

Volumn 152, Issue 4, 2011, Pages 1300-1313

  Jaworski, Diane M ^a   Sideleva, Olga ^a   Stradecki, Holly M ^a   Langlois, Garret D ^a   Habibovic, Aida ^a   Satish, Basanthi ^a   Tharp, William G ^a   Lausier, James ^a   LaRock, Kyla ^a   Jetton, Thomas L ^a   Peshavaria, Mina ^a   Pratley, Richard E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 2; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; FEMALE; GLUCOSE TOLERANCE; HOMEOBOX; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; DIETARY FATS; FEMALE; IMMUNOENZYME TECHNIQUES; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LEPTIN; MALE; MATRIX METALLOPROTEINASE 14; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; OBESITY; POLYMERASE CHAIN REACTION; SEX FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; WEIGHT GAIN;

EID: 79953206246     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1029     Document Type: Article

References (71)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR 2010 Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241
2. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM 2010 Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 303:242-249
3. Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, Schwartz AV, Kritchevsky S, Newman AB 2003 Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26:372-379 (Pubitemid 36929058)
4. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB, Goodpaster B, Visser M, Harris TB 2005 Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 81: 903-910 (Pubitemid 41725001)
5. Yki-Järvinen H 2005 Fat in the liver and insulin resistance. Ann Med 37:347-356 (Pubitemid 41379841)
6. Rodríguez D, Morrison CJ, Overall CM 2010 Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 1803:39-54
7. Pendás AM, Folgueras AR, Llano E, Caterina J, Frerard F, Rodríguez F, Astudillo A, Noël A, Birkedal-Hansen H, López-Otín C 2004 Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol Cell Biol 24:5304-5313 (Pubitemid 38738165)
8. Maquoi E, Demeulemeester D, Vörös G, Collen D, Lijnen HR 2003 Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 89:696-704 (Pubitemid 36456967)
9. Lijnen HR, Van HB, Frederix L, Rio MC, Collen D 2002 Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity. Thromb Haemost 87:530-535 (Pubitemid 34232497)
10. Chun TH, Inoue M, Morisaki H, Yamanaka I, Miyamoto Y, Okamura T, Sato-Kusubata K, Weiss SJ 2010 Genetic link between obesity and MMP14-dependent adipogenic collagen turnover. Diabetes 59:2484-2494
11. Van Hul M, Lijnen HR 2008 A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost 6:1198-1206 (Pubitemid 351863377)
12. Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ 2006 A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 125:577-591
13. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H 1999 MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92 (Pubitemid 29468632)
14. Van Hul M, Piccard H, Lijnen HR 2010 Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development. Thromb Haemost 104:165-171
15. Lijnen HR, Van Hoef B, Rodriguez JA, Paramo JA 2009 Stromelysin-2 (MMP-10) deficiency does not affect adipose tissue formation in a mouse model of nutritionally induced obesity. Biochem Biophys Res Commun 389:378-381
16. Derosa G, Ferrari I, D'Angelo A, Tinelli C, Salvadeo SA, Ciccarelli L, Piccinni MN, Gravina A, Ramondetti F, Maffioli P, Cicero AF 2008 Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium 15:219-224
17. Brew K, Nagase H 2010 The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803:55-71
18. Stetler-Stevenson WG 2008 Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 1:re6
19. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E 2003 Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 89:249-255 (Pubitemid 36227275)
20. Gerin I, Louis GW, Zhang X, Prestwich TC, Kumar TR, Myers Jr MG, Macdougald OA, Nothnick WB 2009 Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1. Endocrinology 150:1697-1704
21. Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, Tornei F, Bertucci P, Iacobini C, Serino M, Porzio O, Hribal ML, Folli F, Khokha R, Urbani A, Lauro R, Pugliese G, Federici M 2009 Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 136:663-672.
22. Wang Z, Juttermann R, Soloway PD 2000 TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275:26411-26415
23. Jetton TL, Lausier J, LaRock K, Trotman WE, Larmie B, Habibovic A, Peshavaria M, Leahy JL 2005 Mechanisms of compensatory β-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 54:2294-2304 (Pubitemid 41134255)
24. Peshavaria M, Larmie BL, Lausier J, Satish B, Habibovic A, Roskens V, Larock K, Everill B, Leahy JL, Jetton TL 2006 Regulation of pancreatic β-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 55:3289-3298 (Pubitemid 44923585)
25. Lluri G, Jaworski DM 2005 Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation. Muscle Nerve 32:492-499
26. Junqueira LC, Cossermelli W, Brentani R 1978 Differential staining of collagens type I, II and III by sirius red and polarization microscopy. Arch Histol Jpn 41:267-274
27. Levin BE 2006 Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philos Trans R Soc Lond B Biol Sci 361:1107-1121 (Pubitemid 44874223)
28. Jaworski DM, Boone J, Caterina J, Soloway P, Falls WA 2005 Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice. Brain Res 1051:81-89 (Pubitemid 40982629)
29. Ballian N, Hu M, Liu SH, Brunicardi FC 2007 Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans. Pancreas 35:199-206 (Pubitemid 47482510)
30. Christiaens V, Lijnen HR 2010 Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 318:2-9
31. Stetler-Stevenson WG, Seo DW 2005 TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol Med 11:97-103 (Pubitemid 40348986)
32. Clark IM, Swingler TE, Sampieri CL, Edwards DR 2008 The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40:1362-1378
33. Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, Jaworski DM, Oudit GY, Kassiri Z 2010 TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMPactivity despite lack of MMP2 activation. Circ Res 106: 796-808
34. Lluri G, Langlois GD, Soloway PD, Jaworski DM 2008 Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and β1 integrin expression in vitro. Exp Cell Res 314:11-24 (Pubitemid 350182445)
35. Derosa G, D'Angelo A, Tinelli C, Devangelio E, Consoli A, Miccoli R, Penno G, Del Prato S, Paniga S, Cicero AF 2007 Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab 33:129-134
36. Zhou YP, Madjidi A, Wilson ME, Nothhelfer DA, Johnson JH, Palma JF, Schweitzer A, Burant C, Blume JE, Johnson JD 2005 Matrix metalloproteinases contribute to insulin insufficiency in Zucker diabetic fatty rats. Diabetes 54:2612-2619 (Pubitemid 41233582)
37. Derosa G, D'Angelo A, Scalise F, Avanzini MA, Tinelli C, Peros E, Fogari E, Cicero AF 2007 Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels 22:361-370 (Pubitemid 350201431)
38. Fiorentino L, Vivanti A, Cavalera M, Marzano V, Ronci M, Fabrizi M, Menini S, Pugliese G, Menghini R, Khokha R, Lauro R, Urbani A, Federici M 2010 Increased tumor necrosis factor a-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51:103-110
39. Monroy A, Kamath S, Chavez AO, Centonze VE, Veerasamy M, Barrentine A, Wewer JJ, Coletta DK, Jenkinson C, Jhingan RM, Smokler D, Reyna S, Musi N, Khokka R, Federici M, Tripathy D, DeFronzo RA, Folli F 2009 Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans. Diabetologia 52:2169-2181
40. Rosenberg GA 2002 Matrix metalloproteinases in neuroinflammation. Glia 39:279-291
41. Descamps FJ, Van den Steen PE, Martens E, Ballaux F, Geboes K, Opdenakker G 2003 Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin. FASEB J 17:887-889
42. Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A 2005 Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem Biophys Res Commun 333:1011-1016 (Pubitemid 40854257)
43. Stradecki HM, Jaworski DM 22 December 2010 Hyperphagia and leptin resistance in tissue inhibitor of metalloproteinase-2 (TIMP-2) deficient mice. J Neuroendocrinol 10.1111/j.1365-2826.2010.02105.x
44. Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM 2010 Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci 30:15337-15357
45. Ethell IM, Ethell DW 2007 Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 85:2813-2823 (Pubitemid 47523564)
46. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D 2002 Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 22:374-379 (Pubitemid 34218741)
47. Demeulemeester D, Collen D, Lijnen HR 2005 Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Commun 329:105-110 (Pubitemid 40255427)
48. Kralisch S, Bluher M, Tonjes A, Lossner U, Paschke R, Stumvoll M, Fasshauer M 2007 Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. Eur J Endocrinol 156:257-261 (Pubitemid 46554521)
49. Scroyen I, Cosemans L, Lijnen HR 2009 Effect of tissue inhibitor of matrix metalloproteinases-1 on in vitro and in vivo adipocyte differentiation. Thromb Res 124:578-583
50. Demeulemeester D, Scroyen I, Voros G, Snoeys J, De Geest B, Collen D, Lijnen HR 2006 Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development. Thromb Haemost 95:1019-1024 (Pubitemid 43933760)
51. Lluri G, Langlois GD, McClellan B, Soloway PD, Jaworski DM 2006 Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a β1 integrin-mediated mechanism. J Neurobiol 66:1365-1377 (Pubitemid 44713814)
52. Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M 2001 Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50:2080-2086 (Pubitemid 33643675)
53. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ 2002 Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730-10735
54. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR 2002 Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51:1093-1101 (Pubitemid 34438355)
55. Pérez-Martínez L, Jaworski DM 2005 Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an antimitogenic signal. J Neurosci 25:4917-4929 (Pubitemid 40712835)
56. Kaiser N, Yuli M, Uçkaya G, Oprescu AI, Berthault MF, Kargar C, Donath MY, Cerasi E, Ktorza A 2005 Dynamic changes in β-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomysobesus: impact of glycemic control. Diabetes 54:138-145 (Pubitemid 40105105)
57. Kahn SE 2001 Clinical review 135: the importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047-4058 (Pubitemid 32848511)
58. Liu S, Mauvais-Jarvis F 2010 Minireview: estrogenic protection of β-cell failure in metabolic diseases. Endocrinology 151:859-864
59. Yamabe N, Kang KS, Zhu BT 2010 Beneficial effect of 17β-estradiol on hyperglycemia and islet β-cell functions in a streptozotocin-induced diabetic rat model. Toxicol Appl Pharmacol 249:76-85
60. Liu S, Le May C, Wong WP, Ward RD, Clegg DJ, Marcelli M, Korach KS, Mauvais-Jarvis F 2009 Importance of extranuclear estrogen receptor-α and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58:2292-2302
61. Kautzky-Willer A, Handisurya A 2009 Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest 39:631-648
62. Boden G, Shulman GI 2002 Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32:14-23 (Pubitemid 41704996)
63. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176 (Pubitemid 30483118)
64. Prentki M, Nolan CJ 2006 Islet β cell failure in type 2 diabetes. J Clin Invest 116:1802-1812 (Pubitemid 44033300)
65. Jaworski DM, Soloway P, Caterina J, Falls WA 2006 Tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice display motor deficits. J Neurobiol 66:82-94 (Pubitemid 41829030)
66. Stump CS, Henriksen EJ, Wei Y, Sowers JR 2006 The metabolic syndrome: role of skeletal muscle metabolism. Ann Med 38:389-402 (Pubitemid 44484877)
67. Escribano O, Guillén C, Nevado C, Gómez-Hernández A, Kahn CR, Benito M 2009 β-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform. Diabetes 58:820-828
68. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97
69. Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, Accili D, Goodyear LJ, Kahn CR 1998 A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569 (Pubitemid 128379082)
70. Zong H, Bastie CC, Xu J, Fassler R, Campbell KP, Kurland IJ, Pessin JE 2009 Insulin resistance in striated muscle-specific integrin receptor β1-deficient mice. J Biol Chem 284:4679-4688
71. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, Fässler R, Gu G, Gerber HP, Ferrara N, Melton DA, Lammert E 2006 The vascular basement membrane: a niche for insulin gene expression and β cell proliferation. Dev Cell 10:397-405